Free Trial
NASDAQ:EVLO

Evelo Biosciences (EVLO) Stock Price, News & Analysis

Evelo Biosciences logo
$0.0005 0.00 (0.00%)
As of 09/5/2025

About Evelo Biosciences Stock (NASDAQ:EVLO)

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
N/A
52-Week Range
$0.00
$0.02
Volume
2 shs
Average Volume
9,482 shs
Market Capitalization
$9.49 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EVLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVLO Stock News Headlines

+2,400% return last time this happened
Porter Stansberry has built his reputation on bold predictions that challenge the mainstream — from the 2007 financial crisis to the dollar’s ongoing decline. Now, he and his top analyst say they’ve uncovered what could be the “next MicroStrategy” moment. Back in 2020, MicroStrategy quietly pivoted into Bitcoin, and the result was a 2,400% gain for investors in just over five years. Today, Porter believes a little-known financial services firm could be set up for a similar asymmetric move — one with multiple catalysts converging in the months ahead.tc pixel
Evelo Biosciences, Inc. (EVLO)
See More Headlines

EVLO Stock Analysis - Frequently Asked Questions

Evelo Biosciences' stock was trading at $0.0005 on January 1st, 2025. Since then, EVLO stock has increased by 0.0% and is now trading at $0.0005.

Evelo Biosciences, Inc. (NASDAQ:EVLO) released its quarterly earnings data on Wednesday, October, 27th. The company reported ($12.60) earnings per share for the quarter, missing analysts' consensus estimates of ($10.80) by $1.80.

Evelo Biosciences's stock reverse split before market open on Friday, June 30th 2023.The 1-20 reverse split was announced on Friday, June 30th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 30th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Evelo Biosciences (EVLO) raised $85 million in an IPO on Wednesday, May 9th 2018. The company issued 5,300,000 shares at $15.00-$17.00 per share. Morgan Stanley, Cowen and BMO Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

Shares of EVLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evelo Biosciences investors own include Sangamo Therapeutics (SGMO), Fulcrum Therapeutics (FULC), CymaBay Therapeutics (CBAY), Provention Bio (PRVB), VIVUS (VVUS), Meta Platforms (META) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
10/27/2021
Today
9/06/2025
Next Earnings (Estimated)
11/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EVLO
CIK
1694665
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
18,983,000
Free Float
18,789,000
Market Cap
$9.49 thousand
Optionable
No Data
Beta
0.85

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:EVLO) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners